U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07526870) titled 'Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore Improvement' on April 03.
Brief Summary: This study aims to evaluate the efficacy and safety of microdoses of botulinum toxin type A (microtoxin) for improving periocular skin quality and reducing fine wrinkles. Botulinum toxin is commonly used in aesthetic medicine; however, its use in microdoses has been proposed to achieve more natural results with fewer adverse effects.
Participants with periocular rhytids will receive intradermal injections of diluted botulinum toxin. Clinical outcomes will include improvement in skin texture, wrinkle reduction, and patient ...